Finance

Lists
002788:SHE
Luyan Pharma Co Ltd
CNÂ¥9.95
-0.40%
(-0.040) 1D
Oct 16, 3:04:15 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 002788...
Open
CNÂ¥10.18
High
CNÂ¥10.30
Low
CNÂ¥9.86
Mkt. cap
4.10B
Avg. vol.
12.04M
Volume
9.46M
Dividend
3.52%
Quarterly dividend
CNÂ¥0.09
Ex-dividend date
Jul 10, 2026
P/E ratio
14.35
52-wk high
CNÂ¥28.29
52-wk low
CNÂ¥8.20
EPS
CNÂ¥0.69
Shares outstanding
388.52M
No. of employees
6K
Open
CNÂ¥10.18
High
CNÂ¥10.30
Low
CNÂ¥9.86
Mkt. cap
4.10B
Avg. vol.
12.04M
Volume
9.46M
Dividend
3.52%
Quarterly dividend
CNÂ¥0.09
Ex-dividend date
Jul 10, 2026
P/E ratio
14.35
52-wk high
CNÂ¥28.29
52-wk low
CNÂ¥8.20
EPS
CNÂ¥0.69
Shares outstanding
388.52M
No. of employees
6K
News stories
From web sources and news partners
About Luyan Pharma Co Ltd
CEO-
Employees5.72K
Founded1992
Headquarters-
SectorHealth care provider
Websiteluyan.com.cn
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
5.46B
5.39B
5.35B
5.23B
Cost of goods sold
5.09B
5.00B
4.99B
4.87B
Cost of revenue
5.09B
5.00B
4.99B
4.87B
Research and development expenses
1.44M
2.25M
1.84M
1.93M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
217.12M
237.89M
205.91M
206.79M
Operating expense
231.15M
258.75M
216.42M
224.70M
Total operating expenses
5.32B
5.26B
5.21B
5.09B
Operating income
134.38M
135.70M
142.74M
138.98M
Other non operating income
-3.10M
-4.84M
-3.05M
-2.99M
EBT including unusual items
84.93M
87.97M
90.19M
98.79M
EBT excluding unusual items
90.27M
88.76M
100.72M
95.86M
Income tax expense
19.91M
27.45M
24.15M
25.02M
Effective tax rate
23.44%
31.21%
26.78%
25.32%
Other operating expenses
10.25M
17.00M
10.64M
16.64M
Net income
65.14M
61.22M
67.94M
75.07M
Net profit margin
1.19%
1.14%
1.27%
1.43%
Earnings per share
-
-
-
-
Interest and investment income
533.34K
420.68K
462.06K
630.56K
Interest expense
-40.55M
-43.29M
-39.44M
-40.79M
Net interest expenses
-40.02M
-42.87M
-38.98M
-40.16M
Depreciation and amortization charges
-
-
-
-
EBITDA
151.03M
153.96M
161.00M
160.09M
Gain or loss from assets sale
98.17K
-264.93K
-
481.57K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps